Impact of genetic variation of HIV-1 on drug resistance development

Author： Snoeck Joke   Vandamme Anne-Mieke   Camacho Ricardo Jorge  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.2, Iss.3, 2007-05, pp. : 303-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting HIV: antiretroviral therapy and development of drug resistance

By Menendez-Arias L.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 8, 2002-08 ,pp. : 381-388

Elsevier

Access to resources Recommend Favorite

Guidelines for HIV-1 drug resistance testing

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Drug Resistance, Virus Fitness and HIV-1 Mutagenesis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4065-4070

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: HIV-1 Reverse Transcriptase Inhibitors: Drug Resistance and Drug Development (Executive Editors: Nicolas Sluis-Cremer and Ted Ross)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1809-1810

Bentham Science Publishers

Access to resources Recommend Favorite

Transmitted drug resistance in HIV-1 increasing?

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite